Korea Medical Device Import License & KLH Setup for Foreign Companies (2026 Guide)

Korea is an attractive medical device market in 2026, but foreign founders often underestimate one basic fact: you do not enter this market with a normal trading company alone. If you plan to import and commercialize devices in Korea, you need the right Korean entity structure, the right responsible party, and the right licensing path with the Ministry of Food and Drug Safety (MFDS).

For many overseas manufacturers, the real question is not just “How do we sell in Korea?” It is “Should we appoint a Korean License Holder (KLH), rely on a distributor, or set up our own Korean subsidiary and hold the import license directly?”

This guide explains the business logic behind that decision and the mistakes that delay foreign market entry.

CTA: 📩 Contact us at sma@saemunan.com

Table of Contents

1. Why this matters in 2026

Korea remains one of Asia’s most sophisticated healthcare markets. Buyers expect strong documentation, local accountability, and post-market responsiveness. That means regulatory readiness is part of market entry, not an afterthought.

Current guidance and industry practice continue to expect a Korean-side responsible party with a real business presence. Import activity and product registration cannot be handled casually through a freight company or informal sales partner.

For foreign device makers, the 2026 trend is clear:

• regulators want a clearly identified Korean responsible entity,
• distributors want liability boundaries clearly drafted,
• local buyers prefer vendors with stable Korean operational support,
• and delays usually come from entity design, not product demand.

If your Korea entry plan starts with sales outreach before the licensing structure is mapped, you are already taking avoidable risk.

2. What MFDS expects from foreign manufacturers

First, anyone intending to import medical devices into Korea generally needs the proper import business license rather than only a general company registration. Second, foreign manufacturers that do not have their own registered Korean business often need a Korea-based license holder to act as the local regulatory interface.

That local interface matters because Korea’s system is not only about customs clearance. It is about accountability for:

• product registration,
• labeling and technical file consistency,
• adverse event handling,
• recalls or corrective actions,
• document retention,
• and communications with MFDS.

3. What a Korean License Holder (KLH) does

A Korean License Holder (KLH) is the Korean entity that holds the relevant product license and acts as the responsible Korean-side party for a foreign manufacturer.

Based on industry guidance, a KLH typically must:

• be established in Korea,
• maintain a registered office and business license,
• obtain the relevant medical device import license,
• register or appoint a qualified quality manager,
• and manage regulatory submissions and ongoing compliance.

The KLH is not just a mailbox. It often controls a strategically important part of your Korea business because it may hold the product registration history and serve as the contact point for MFDS.

Why KLH choice is a major business decision

Foreign companies usually consider three models:

1. Distributor as KLH
   Fastest to launch, but the distributor gains leverage because the license path sits with them.

2. Independent regulatory firm as KLH
   Better separation between compliance and commercial sales, but still requires strong contracts.

3. Your own Korean subsidiary as KLH
   Highest control, strongest long-term platform, but higher setup and operating burden.

If Korea is a test market, a third-party KLH may be fine. If Korea is strategic, relying entirely on a distributor-held license often becomes painful later.

4. Entity options for foreign companies

Foreign manufacturers normally choose one of the following structures.

Option A: Appoint a Korean distributor

This is common when the manufacturer wants speed and low fixed cost.

Pros

• fastest commercial launch,
• fewer internal staffing needs,
• lower upfront Korea overhead.

Cons

• less control over customer relationships,
• weaker control over regulatory files,
• harder distributor switch later,
• license and data access disputes can arise.

Option B: Use an independent Korean compliance platform

This can work when you want local compliance without giving a sales partner too much power.

Pros

• cleaner separation of regulatory and sales functions,
• easier multi-distributor strategy,
• improved negotiation position.

Cons

• another service provider to manage,
• still requires careful agreement drafting,
• may not solve warehousing and commercial execution by itself.

Option C: Set up a Korean subsidiary

This is often the best structure if you plan long-term direct sales, local hiring, local inventory, or Korean fundraising.

Pros

• maximum control,
• direct ownership of local licenses and relationships,
• easier coordination of customs, tax, payroll, and regulatory work.

Cons

• incorporation, bookkeeping, payroll, office, and corporate compliance costs,
• need for internal operating discipline,
• longer launch preparation.

5. Import license prerequisites

Foreign companies often focus on product classification before they confirm business prerequisites. That sequence can backfire.

Before acting as the importer or KLH, the Korean-side entity generally needs:

• a registered Korean business,
• a real office or recognized business place,
• the appropriate import-business authorization,
• a quality management setup,
• and internal document control procedures.

Practical Korea entry usually also requires alignment across:

• court or corporate registration,
• tax registration,
• customs readiness,
• bank account opening,
• and regulatory staffing.

Basic setup table

6. Product approval and registration workflow

The exact route depends on device classification and product features, but the practical workflow usually looks like this:

1. Confirm product classification and Korea market strategy.
2. Decide who will be the KLH.
3. Establish the Korean entity or local representative structure.
4. Secure business registration and import-license prerequisites.
5. Prepare the technical file, labeling, and supporting documentation.
6. Submit registration or approval materials to MFDS through the proper channel.
7. Address supplemental questions or corrections.
8. Complete import and commercialization steps, including distribution controls.

Do not confuse business setup with product approval

A Korean subsidiary may be fully incorporated and still not be commercially ready to import a device. Conversely, a distributor may be eager to sell before the documents are regulatory-ready. The legal entity and the product approval track need to move together.

7. Quality manager and compliance staffing

Korean practice places real importance on compliance staffing. Industry guidance repeatedly notes that a KLH must maintain a quality manager or equivalent responsible function that satisfies local expectations.

That matters because Korea treats post-market compliance seriously. Once products are in circulation, someone must be able to manage:

• complaints,
• corrective actions,
• product traceability,
• document updates,
• and communications with authorities.

If you are building your own subsidiary, do not leave this until the last week. The quality role affects licensing readiness and SOP design.

8. Customs, warehousing, and distribution alignment

A medical device market-entry plan fails when regulatory, customs, and sales teams work in silos.

Questions you should answer early:

• Who is the importer of record?
• Where will inventory be stored?
• Who controls Korean labeling and inserts?
• How will field safety notices be distributed?
• Who retains shipment and batch records?

For many companies, the cleanest design is this: one Korean entity or KLH controls import and compliance, while distribution contracts clearly allocate logistics and sales activity.

9. Contract issues between manufacturer, KLH, and distributor

This is the most overlooked part.

Your agreements should clearly define:

• ownership and access rights to registration dossiers,
• who may transfer or rely on approvals,
• who bears recall costs,
• who handles adverse event reporting,
• trademark and labeling rights,
• termination procedures,
• and post-termination cooperation.

A practical warning

If a distributor is also the KLH, and the relationship breaks down, the foreign manufacturer may face a very expensive reset. That can mean re-documentation, re-negotiation, sales interruption, and immediate customer confusion.

10. Timeline and cost planning

Typical timelines vary widely by product category and documentation quality, but foreign companies should budget separately for:

• entity setup,
• regulatory strategy,
• KLH or local service fees,
• quality staffing,
• translation and dossier preparation,
• customs and warehouse onboarding,
• and post-launch compliance.

A practical launch plan in Korea often takes longer than founders expect because bank setup, office substance, and technical review do not move at the same speed.

Build a staged plan:

• Stage 1: market-entry structure decision,
• Stage 2: Korean entity or KLH onboarding,
• Stage 3: licensing and registration,
• Stage 4: import and launch.

11. Common mistakes foreign companies make

The most common mistakes I see are:

1. Treating Korea entry as only a distributor deal.
2. Choosing a KLH without exit-right planning.
3. Assuming a general Korean company registration is enough.
4. Underestimating quality-manager requirements.
5. Separating customs planning from regulatory planning.
6. Translating technical documents too late.
7. Signing sales commitments before the legal route is stable.

These mistakes do not just delay launch. They weaken negotiating leverage for years.

12. 2026 practical trends

In 2026, foreign companies are increasingly asking for more control over Korea market entry even when they start small.

Three patterns stand out:

• more companies want independent compliance structures instead of distributor capture,
• more founders want Korea subsidiaries once they see the value of direct control,
• and more investors ask whether the Korea regulatory pathway is actually scalable before funding expansion.

For medtech and device businesses, the cleanest winners are the ones that treat entity setup, regulatory filing, and commercial contracts as one integrated project.

13. FAQ

Q1. Can a foreign manufacturer import medical devices into Korea without a local company?
Usually not in a simple direct way. In practice, you normally need a qualified Korean-side license holder or your own Korean entity structure.

Q2. Is a KLH always a distributor?
No. The KLH can be a distributor, an independent service provider, or your own Korean subsidiary.

Q3. Should we let our distributor hold the license?
It can work for a short-term test, but long-term it often reduces your control over pricing, customers, and regulatory continuity.

Q4. Do we need a real office in Korea?
In practice, Korea expects real business substance for regulated activity. A proper registered office and business setup are important.

Q5. How early should we start planning?
Before you sign your Korea commercial deal. The best time to structure licensing is at the start, not after the first purchase order.

Need help setting up a Korean subsidiary, reviewing KLH risk, or aligning licensing with import and tax planning? 📩 Contact us at sma@saemunan.com